2138 — EC Healthcare Income Statement
0.000.00%
- HK$758.54m
- HK$1.96bn
- HK$4.21bn
- 68
- 88
- 26
- 68
Annual income statement for EC Healthcare, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,949 | 2,080 | 2,920 | 3,875 | 4,211 |
Cost of Revenue | |||||
Gross Profit | 1,733 | 1,845 | 2,570 | 3,322 | 3,545 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,570 | 1,796 | 2,549 | 3,688 | 4,099 |
Operating Profit | 378 | 285 | 371 | 187 | 112 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 361 | 266 | 321 | 136 | 16.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 310 | 226 | 271 | 107 | 15.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 287 | 193 | 198 | 69.7 | -18.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 287 | 193 | 198 | 69.7 | -18.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.287 | 0.11 | 0.153 | 0.027 | -0.016 |
Dividends per Share |